$AZTR Cashflow Statement | Understand Stock

$AZTR

$1.12 -$0.41 (26.8%) Close

$AZTR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Loss on lease modification
Amortization of right-of-use assets
Change in foreign currency rates on remeasurement of Canadian fixed assets
Accrued interest on convertible notes
Stock based compensation
Change in fair value of warrant liability
Loss on issuance of common stock
Change in fair value of convertible notes
Forgiveness of accounts payable
Loss on disposal of property and equipment
Impairment of intangible assets and deferred patent costs
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses
Other assets
Tax credits receivable
Income tax payable/receivable
Accounts payable and accrued expenses
Operating lease liability
Contract liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sale of property and equipment
Capitalization of deferred patent costs
Capitalization of patent and trademark costs
Deferred patent costs
Capitalization of licenses
Net cash used in investing activities
Cash flows from financing activities
Payment of deferred offering/issuance costs
Principal payments on finance leases
Proceeds from public offerings, net
Proceeds from private placement, net
Proceeds from equity line of credit, net
Repayment of insurance premium financing liability
Proceeds from exercise of stock options
Net cash provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of non-cash investing and financing information:
Conversion of Series A, A-1, and B Convertible Preferred Stock to common stock
Obtaining a right-of-use asset in exchange for financing lease liability
Conversion of note to common stock
Conversion of note to Series B Convertible Preferred Stock
Financed insurance premium exchanged for prepaid insurance
Purchases of fixed assets in accounts payable
Conversion of Series A, A-1, B Convertible Preferred Stock to Common Stock

Comments